COMMUNIQUÉS West-GlobeNewswire

Neuphoria Responds to the announcement made by London-listed Scancell Holdings plc
26/06/2026
Neuphoria Therapeutics confirms it is in talks with Scancell Holdings plc about a possible combination BURLINGTON, Mass., June 26, 2026 (GLOBE NEWSWIRE) -- Neuphoria Therapeutics Inc. (“Neuphoria” or the “Company”) ( [...]
Crescent Biopharma Announces Grants of Inducement Awards
26/06/2026
WALTHAM, Mass., June 26, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma , Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies [...]
VitalHub Announces Results of Annual General Meeting of Shareholders
26/06/2026
TORONTO, June 26, 2026 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (the “Company” or “VitalHub”) announced today the voting results from its annual general meeting of shareholders held virtually on June [...]
Nordic Naturals Ultimate Omega Featured in New Erewhon Smoothie by J Balvin
26/06/2026
Watsonville, CA, June 26, 2026 (GLOBE NEWSWIRE) -- Nordic Naturals , the #1 selling fish oil brand in the U.S.‡, today announced that its award-winning Ultimate Omega® is a featured ingredient in Erewhon's newly [...]
Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards and Acceptance of Plan to Regain Compliance
26/06/2026
BEDMINSTER, N.J., June 26, 2026 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (the “Company”) (NYSE American: MTNB) announced today that on June 24, 2026, it received a notice (the “Notice”) from the NYSE [...]
Board decision to file for bankruptcy
26/06/2026
Ghent, June 26, 2026 (GLOBE NEWSWIRE) -- PRESS RELEASE | REGULATED INFORMATION - INSIDE INFORMATION 26 June 2026, 05:15 pm CEST Ghent, Belgium, 26 June 2026 – Sequana Medical NV (Euronext Brussels: SEQUA) (the " Company [...]
FDA Proposes Rule That Would Help Hold Foreign Tobacco Product Manufacturers Accountable, Protect Public Health
26/06/2026
If finalized, rule would level the playing field between American and foreign businesses Silver Spring, MD, June 26, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today issued a proposed rule that, if [...]
Cosmos Health Signs Distribution Agreement With IMC, Owner of Qatar's Largest Pharmacy Chain; Secures Initial Purchase Order of 31,000 Sky Premium Life Units
26/06/2026
CHICAGO, June 26, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced a distribution agreement [...]
Johnson & Johnson presents new IMAAVY®▼ (nipocalimab) data at European Academy of Neurology (EAN) 2026 Congress reinforcing sustained disease control in generalised myasthenia gravis
26/06/2026
New analyses from the Phase 3 Vivacity-MG3 study support the impact of nipocalimab in anti-AChR+ a , anti-MuSK+ b adult patients with generalised myasthenia gravis (gMG) including those early in their disease, [...]
Siren Biotechnology Awarded $8M in Non-Dilutive Grant Funding from the California Institute for Regenerative Medicine (CIRM) to Support Clinical Development of SRN-101 in High-Grade Glioma
26/06/2026
SAN FRANCISCO, June 26, 2026 (GLOBE NEWSWIRE) -- Siren Biotechnology, pioneers of Universal AAV Immuno-Gene Therapy for cancer, today announced that the California Institute for Regenerative Medicine (CIRM) has awarded [...]
Thought Leadership & Innovation Foundation Founder Bill Oldham Launches New Book: Beyond Better Data: What Actually Changes Health Care?
26/06/2026
MCLEAN, Va., June 26, 2026 (GLOBE NEWSWIRE) -- The Thought Leadership & Innovation Foundation (TLI) proudly announces the release of Beyond Better Data: What Actually Changes Health Care? a new book by Founder and [...]
Replimune Announces FDA Acceptance of RP1 Biologics License Application Resubmission for Advanced Melanoma
26/06/2026
FDA decision expected by August 2, 2026 WOBURN, Mass., June 26, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company pioneering the development of novel oncolytic [...]
Vaxart Publishes Presentation Urging Shareholders to Vote “FOR” ALL Six of the Company’s Highly Qualified Director Nominees on the WHITE Proxy Card TODAY
26/06/2026
Details Strategic Actions Taken by the Board to Advance the Company’s Pipeline and Drive Value Creation Vaxart’s Purpose-Built Board Brings the Proven Expertise Needed to Oversee its Next Phase of Growth Dissident [...]
Standard Dental Labs Inc. Signs Letter of Intent to Acquire Additional Dental Laboratory in the Tampa Bay Region
26/06/2026
ORLANDO, Fla., June 26, 2026 (GLOBE NEWSWIRE) -- Standard Dental Labs Inc. (OTCQB: TUTH) ("SDL" or the "Company"), a rapidly growing dental laboratory consolidator focused on the Florida market, today announced that it [...]
CDT Highlights Sarborg's Application of Quantum Computing to Solid-Form Development
26/06/2026
NAPLES, Fla. and CAMBRIDGE, United Kingdom, June 26, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today notes the announcement from Sarborg Limited regarding the expansion of its [...]
Sienna Completes Acquisition in Greater Ottawa Area
26/06/2026
MARKHAM, Ontario, June 26, 2026 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (" Sienna " or the " Company ") (TSX: SIA) announced today that it has completed its previously disclosed acquisition of Rockland Manor, a [...]
LIXTE Joins Russell Microcap Index
26/06/2026
BOCA RATON, Fla., June 26, 2026 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT), today announced its inclusion in the Russell Microcap ® Index, effective after the close [...]
Nkarta to Participate in H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
26/06/2026
SOUTH SAN FRANCISCO, Calif., June 26, 2026 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat autoimmune [...]
Medicenna Therapeutics Reports Fiscal Year 2026 Financial Results and Operational Highlights
26/06/2026
MDNA11, as a single agent or in combination with pembrolizumab, continues to demonstrate compelling anti-tumor activity in patients with advanced or metastatic cutaneous melanoma, endometrial cancer and gastrointestinal [...]

Pages